Alternatives to Organovo

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

AI-driven digital twin of embryo development for cell-based therapies.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Mapping cell-cell communication at scale in human tissue.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

BICO Group is a global leader in life science solutions, enabling the bioprinting and analysis of cells, tissues, and organs.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids.

AI-powered platform accelerating biological research and drug discovery.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

A global oncology company developing and commercializing innovative cancer treatments.